A Prospective, Single-arm, Open-Label, Single-Centre Behavioural Study to Evaluate the Impact of Shilajit Supplements in increasing Quality of Life in Men - NI

Azuretale Inc0 个研究点目标入组 50 人开始时间: 待定最近更新: 2024年7月22日

试验速览

暂无简介。

•1.Age Range: Adult males aged between 30 and 60 years.
•2.Health Status: Individuals experiencing reduced vitality or cognitive issues but generally in good health.
•3.Consent:Willing to provide informed consent and adhere to study protocol.
•4.Availability: Able to participate in all scheduled visits and assessments during the 30- day study period.

•1.Chronic Diseases: Individuals with severe chronic diseases, especially uncontrolled diabetes, cardiovascular diseases, or severe neurological disorders.
•2.Current Medication: Use of cognitive enhancers, testosterone supplements, or other medications that might interfere with the study outcomes.
•3.Substance Abuse: History of alcohol or substance abuse within the last six months.
•4.Psychiatric Conditions: Significant psychiatric disorders that could affect compliance or skew results.
•5.Other Clinical Trials: Participation in another clinical trial within the last three months.

发起方

Azuretale Inc